Related Experiment Videos
cDNA cloning and mRNA distribution of a mouse very long-chain acyl-CoA synthetase
J Berger1, C Truppe, H Neumann
1Institute of Neurology, University of Vienna, Austria. johannes.berger@univie.ac.at
Abstract:
The interaction of the adrenoleukodystrophy protein (ALDP), mutated in the peroxisomal disorder X-linked adrenoleukodystrophy, and the very long-chain acyl-CoA synthetase (VLACS), the enzyme whose function is missing in this disease, remains obscure. As a first step to studying this interaction in wild type versus ALDP-deficient mice, we have cloned a VLACS cDNA from mouse liver. The 1860 bp open reading frame encodes a 620 amino acid protein with a predicted molecular mass of 70.3 kDa. By Northern blot analysis, a 2.6 kbp VLACS mRNA was highly abundant in liver and kidney and present at low levels in brain and testes. By RT-PCR VLACS mRNA was also detected in heart and lung but remained undetectable in skeletal muscle and spleen. In contrast to the peroxisomal beta-oxidation marker acyl-CoA oxidase, whose mRNA level steadily increases during brain development, the VLACS transcript was found at a constant low level from embryo through adulthood, suggesting that additional isoforms may exist in brain.
Insights
Researchers cloned the very long-chain acyl-CoA synthetase (VLACS) gene from mouse liver to study X-linked adrenoleukodystrophy. This enzyme
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by mutations in the adrenoleukodystrophy protein (ALDP).
- The function of very long-chain acyl-CoA synthetase (VLACS), the enzyme deficient in X-ALD, and its interaction with ALDP remain poorly understood.
- Studying VLACS in ALDP-deficient models is crucial for understanding X-ALD pathogenesis.
Purpose of the Study:
- To clone the mouse liver VLACS cDNA as a foundational step for investigating VLACS and ALDP interactions.
- To characterize the VLACS transcript expression pattern in various mouse tissues.
- To provide insights into VLACS gene expression during brain development.
Main Methods:
- Cloning of VLACS cDNA from mouse liver.
- Northern blot analysis to determine VLACS mRNA size and abundance.
- RT-PCR to detect VLACS mRNA in different tissues and developmental stages.
Main Results:
- A 1860 bp VLACS cDNA encoding a 620 amino acid protein (70.3 kDa) was successfully cloned.
- VLACS mRNA (2.6 kbp) was highly expressed in liver and kidney, with lower levels in brain and testes.
- VLACS mRNA was detected in heart and lung but not in skeletal muscle or spleen.
- VLACS transcript levels remained constant during brain development, unlike other peroxisomal markers.
Conclusions:
- The cloning of mouse VLACS provides a critical tool for future studies on X-ALD.
- Tissue-specific expression patterns of VLACS suggest distinct roles in different organs.
- The constant low-level expression of VLACS in the brain may indicate the presence of alternative isoforms or regulatory mechanisms.